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Objectives: This study aimed to analyze the pattern of surgical chemoprophylaxis, surgical
site  infection rate, and to check rationality of surgical chemoprophylaxis based on Kunin’s
criteria.
Materials  and methods: A prospective, observational study was performed on patients under-
going  surgery, in a tertiary care teaching hospital. Data were collected in a pro-forma which
included the patients’ details, prescriptions from date of admission to discharge or any other
outcome  and operative notes. Surgical site infection as deﬁned by Centre for Disease Control
criteria  was recorded. Rationality was assessed based on Kunin’s criteria.
Results:  Total 220 patients were enrolled over a period of one year. Mean hospital stay was
8.67  ± 5.17 days. A total of 2294 drugs were prescribed out of which 840 (36.61%) were
antimicrobials.  Mean duration for pre-operative intravenous antimicrobial therapy was
0.75  ± 0.45 day and for post-operative intravenous antimicrobial therapy was 3.33 ± 2.24
days  while post-operative oral antimicrobial therapy was 4.58 ± 3.34 days. Third genera-
tion  cephalosporins were prescribed most frequently 64.74% and 64.40% pre-operatively and
post-operatively respectively. Antimicrobial prescribing was inappropriate in 52.28%. Total
of  19 patients developed surgical site infection. Surgical site infection rate was  signiﬁcantly
higher  (13.04%) in patients receiving inappropriate chemoprophylaxis (p < 0.01). Surgical
site  infection adds 9.98 days of hospital stay (p < 0.0001) and 3.57 extra drugs (p < 0.0001)
compared  to group without surgical site infection.Conclusion: Inappropriate use of antimicrobials is highly prevalent in surgical chemoprophy-
laxis  leading to higher surgical site infection rate. Adoption of international standard and
formulation  of locally feasible guidelines can help overcome this situation.
13 E Introduction
© 20 As Sir Alexander Fleming predicted in his Nobel Lecture,
“Antimicrobials, since their introduction have been pivotal
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Este é um artigo Open Access sob a licença in the prevention and treatment of infections. However, the
increasing  use of antimicrobials has led to a situation of appro-
lsevier Editora Ltda.    Este é um artigo Open Access sob a licença de CC BY-NC-NDlhotra@gmail.com (S.D. Malhotra), drvarsha4@rediffmail.com
priate  and inappropriate use.”1A surgical site infection (SSI)2
is an infection that occurs after surgery in the part of the
body  where the surgery took place. Surgical site infections
de CC BY-NC-ND
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Table 1 – Kunin’s criteria11 for rationality assessment of
antimicrobial prescriptions.
Category I: Agree with the use of antimicrobial
therapy/prophylaxis, the program is appropriate
Category II: Agree with the use of antimicrobial
therapy/prophylaxis, but a potentially fatal bacterial infection
cannot be ruled out or prophylaxis is probably appropriate,
advantages derived remain controversial
Category  III: Agree with the use of antimicrobial
therapy/prophylaxis, but a different (usually less expensive or
toxic) antimicrobial is preferred
Category  IV: Agree with the use of antimicrobial
therapy/prophylaxis, but a modiﬁed dose is recommended
Category V: Disagree with the use of antimicrobialb r a z j i n f e c t d i
emain among the main causes of post-operative morbidity,
rolonging hospitalization and increasing the cost of medical
reatment  in surgical units.3–4 Antimicrobials play an impor-
ant  role in preventing and treating surgical site infections.
urgical chemoprophylaxis is an important measure before
ny  surgery to prevent SSI. Various guidelines5–8 are available
or  the use of antimicrobials for surgical chemoprophylaxis.
owever it is observed that they are not always followed.9,10
his has led to a worldwide emergence of antimicrobial resis-
ance,  a major public health problem and has signiﬁcant
mpact on treatment and outcomes. To produce the desired
ffect,  antimicrobials have to be safe, efﬁcacious and have
o  be used rationally. Several studies have evaluated pattern
f  use of antimicrobials as surgical chemoprophylaxis, but
here  are very limited studies in recent years on evaluation
f  rationality. Kunin’s criteria are rationality based evalua-
ion  of use of antimicrobials. This methodology is based on
ocal  prescribing patterns and allows for individual evaluation
f  each prescription as opposed to developing general crite-
ia/categories of infections and appropriate antimicrobial use
o evaluate the quality of prescribing by audits. In the past, the
lassiﬁcation  was  mainly based on the authority of infectious
iseases specialists who performed the evaluation.11 Several
tudies  have reported SSI rate or pattern of surgical chemo-
rophylaxis but have not correlated SSI rates with pattern of
urgical  chemoprophylaxis.12–17
This study was  undertaken to evaluate the pattern and
ationality of antimicrobial drug prescribing by surgeons in
erioperative  patients using Kunin’s criteria.11 SSI rate was
alculated  and difference among patients with appropriate
nd  inappropriate surgical chemoprophylaxis was  also ana-
yzed.  The aim of this study was  to evaluate the current pattern
f  surgical chemoprophylaxis among patients undergoing sur-
ical  procedures in a tertiary care hospital and its impact on
SI  rate.
bjectives  of  study
. To assess the current pattern of surgical chemoprophylaxis
and its rationality assessment based on Kunin’s criteria11
and Scottish Intercollegiate Guidelines Network (SIGN)6
core indicators for auditing antimicrobial use in surgical
chemoprophylaxis.
.  To evaluate surgical site infection rate and difference in SSI
rate  if any between appropriate and inappropriate prescrip-
tions.
aterials  and  methods
wo hundred and twenty prescriptions of patients admitted
n  the General Surgery wards  of a tertiary teaching hospi-
al  were  collected prospectively between June 2010 and May
011.  The study protocol, pro-forma, and other documents
ike  patient information sheet and informed consent form in
nglish and local vernacular language were  approved by Insti-
utional  Ethics Committee. All patients undergoing surgery
rrespective of their age and gender were included. Patients
ho  were  not willing to give information were excluded from
he  study. Case records of enrolled patients, admitted fortherapy/prophylaxis, administration is preferred
Category VI: data cannot be judged because of missing information
any operative procedures were recorded in the pro-forma
containing demographic details, chief complaints, diagnosis,
details  of operative procedures and drug details during the
hospital  stay. Class of operation was decided in consulta-
tion  with operating surgeons and was  based on US National
Research Council group criteria.18 SSI rate was calculated as
deﬁned  by CDC,2 rationality assessment was done accord-
ing  to the Kunin’s criteria11 shown in Table 1 based on CDC
1999  Guidelines5 as reference standard and also surgical audit
based  on SIGN guideline criteria.6 The analysis was  done
based  on CDC guidelines because of unavailability of national
or  local guidelines. The generic names of drugs, generic con-
tents  of each formulation were obtained from the patient’s
pharmacy bills. Drugs and formulations which were  not men-
tioned  in the bills were  obtained from local pharmacy stores
and  commercial publications like Indian Drug Review 2010 and
2011.
Statistical  analysis
Data were analyzed by using SPSS 20.0 demo version®. Fisher’s
exact  test (two tailed) was used to determine the signiﬁcance
of  SSI positive rates among different variables and unpaired
t-test  was used to determine the difference between the inap-
propriate  and appropriate prescription groups. Value of p < 0.05
was considered as statistically signiﬁcant.
Results
A total of 220 patients were enrolled in the study of which
141  (64.1%) were males. The age ranges from 13 to 78 years;
with  mean age 38.88 ± 14.18 (mean ± S.D.). About 90% (197)
underwent elective surgeries the rest being emergency sur-
geries.  Most of the operative procedures were  open 207 (94%)
and  the rest were  laparoscopic. General anesthesia was  used
in  8 patients and in the rest either spinal or local anes-
thesia was used. Herniorrhaphy (27.3%) and appendectomy
(20.5%) remained the most frequently performed operative
procedures. Class I, i.e., clean surgeries 105 (47.73%) were
most  frequent, followed by class II, i.e., clean-contaminated
53 (24.09%), class III-contaminated 38 (17.27%), and class IV-
dirty  24 (10.91%) as shown in Table 2. Mean hospital stay was
8.67  ± 5.17 days (mean ± S.D.).
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Table 2 – Distribution of surgeries according to class18 and surgical site infection (SSI)2 rate.
Class Operative procedures % SSI positive patients %
Clean (I) 104 47.27 2 1.92
Clean contaminated (II) 53 24.09 4 7.54
Contaminated (III) 39 17.72 3 7.69
Dirty (IV) 24 
Total 220 
All the patients undergoing operative procedures received
single  intravenous dose of antimicrobial 30 min  before the
surgery,  followed by post-operative intravenous therapy and
further  oral therapy with antimicrobial. Mean duration for pre-
operative intravenous antimicrobial therapy was 0.75 ± 0.45
days.  Mean duration of post-operative intravenous antimi-
crobial  therapy was  3.33 ± 2.24 while post-operative oral
antimicrobial therapy was  4.58 ± 3.34 days. None of the oper-
ative  procedures exceeded more  than 4 h duration.
A  total of 2294 drugs were prescribed out of which
840 (36.61%) were  antimicrobials. Ceftriaxone was  the most
frequently  used antimicrobial pre-operatively (50.64%) and
post-operatively (36.93%) as shown in Fig. 1.
Out of 220 patients, 28 had suspected SSI. Nineteen patients
out  of 28 had microbiologically conﬁrmed SSI, Escherichia coli
(9)  and Staphylococcus aureus (7) being the common pathogens.
SSI  rate was  highest in class IV (41.66%) followed by in class III
(7.69%),  II (7.54%), and was  least in class I (1.92%). SSI rate was
signiﬁcantly  higher in patients who  presented with diabetes
mellitus  (p < 0.0001) and hypertension (p = 0.0048) as shown in
Table 3. SSI positive rate in 61 hernia patients was  2 (1.63%)
while  in 45 appendectomy patients the rate was  1 (2.22%). In
these  patients E. coli was  the most common isolate. Mean age
of  SSI positive patients was  found signiﬁcantly higher as com-
pared  to SSI negative patients (p < 0.001) which is depicted in
Table  3. Patients with age above 40 years showed signiﬁcant
higher  SSI positive rate as compared to patients less than 40
years.  There was  no signiﬁcant difference for SSI rate between
gender,  types of anesthesia and between open and laproscopic
surgery, while emergency surgery showed signiﬁcantly higher
SSI  rate in comparison with elective surgery (p = 0.0073). Mean
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Fig. 1 – Pre-operative and post-operative antimicrobial
drugs.10.91 10 41.66
100 19 8.64
hospital stay for SSI negative patients was 7.81 ± 4.1 and that
for  SSI positive patient was 17.79 ± 6.41, which shows a signif-
icant  increase in mean hospital stay by 9.98 days (p < 0.0001).
Patients  with hospital stay greater than a week had signif-
icantly  higher rate (p < 0.0001) of SSI positivity. Mean drugs
prescribed in SSI negative were 7.43 ± 1.74 and that in SSI
positive  patient was  11 ± 2 yielding a signiﬁcant (p < 0.0001)
increase of 3.57 drugs.
Antimicrobial  prescriptions were categorized as appropri-
ate  (I and II) – 105(47.7%) and inappropriate (III, IV, and V) –
115  (52.3%) based on Kunin’s criteria11 as shown in Table 4.
SSI  rate was signiﬁcantly higher (p < 0.05), in inappropriate
group (13.04%) in comparison with appropriate group (3.8%) as
shown in Table 4. Out of 61 hernia patients, 19 prescriptions
were inappropriate out of which 2 patients had SSI (p = 0.0934).
Out  of 45 appendectomy patients 35 prescriptions were inap-
propriate  and one patient has SSI (p = 1). Rate of SSIs in patients
who  receive inappropriate prophylaxis (as deﬁned by CDC
guideline5) compared with rate of this infection in patients
who  receive appropriate prophylaxis, expressed as a ratio was
found  to be 3.43. Table 5 depicts the process measures and
outcome  measures according to SIGN guidelines.6
Discussion
This study was  aimed to evaluate the current prescribing pat-
tern  along with rationality, its impact on SSI rate and on
hospital  stay and number of extra drugs needed. Previous
study  from Pakistan12 reported 55.7% males lower compared
to  ours 64%, mean age of the patients was 35 ± 17 years, and
somewhat  less compared to our study, i.e., 38.8%.
In our study SSI rate was  8.64% which was  similar to
previous studies.13 In our study E. coli was  most commonly
isolated pathogen, followed by S. aureus which is in accor-
dance  with previous Indian study.19 SSI rate for two most
commonly performed surgeries herniorrhaphy and appendec-
tomy  is comparable to an earlier study carried out in India14
and a worldwide meta analysis study.20 There is no signiﬁ-
cant  difference in SSI rate between genders, this ﬁnding is
similar  to a previous study reported in Iran in 2006.21 SSI rate
increases  with age above 40 years, which was statistically sig-
niﬁcant  at p < 0.0001 and was  similar to study reported from
India.22 SSI rate among patients receiving general anesthesia
in  our study was 16.67% as compared to other modes (7.92%),
which  is in accordance with previous study done in UK.23 SSI
rate  was  higher in emergency surgery than in elective and is
14comparable  to another Indian study. In our study SSI rate
was  signiﬁcantly higher in diabetic and hypertensive patients
which  was also seen in a previous Indian study.22 In our study
there  was no difference in SSI rate between laproscopic and
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Table 3 – Surgical site infection (SSI) rates2 and variables.
SSI negative (n = 201) SSI positive (n = 19) Total (n = 220) p valuea
Mean age 37.71±13.44 51.26±16.21 38.88±14.19 <0.0001
≤40 years 134 6 140 0.0047
>40 years 67 13 80
Gender
Male 131 10 141 0.32
Female 70 9 79
Days of hospital stay 7.81±4.1 17.79±6.41 8.67±5.17 <0.0001
≤7 days 118 1 119
>7 days 83 18  101
No. of drugs given 7.43±1.74 11±2 10.42±3.37 <0.0001
Type of anesthesia
General 15 3  18 0.193
Other SA and LA 186 16 202
Mode of operation
Elective 184 13 197 0.0073
Emergency 17 6 23
Open 188 19 207 0.60
Laproscopic 13 0 13
Co-morbid conditionsb
Diabetes mellitus 2 9 11 <0.0001
Hypertension 10 5 15 0.0048
Using Fischer’s exact two tailed test and unpaired t-test.
o
i
c
E
t
i
p
n
m
o
b
a
o
w
o
ia p < 0.005.
b Four patients presented with both diabetes and hypertension.
pen surgery. A study by Jawien et al.15 reported less SSI rate
n  laproscopic surgery than in open surgery. SSI led to signiﬁ-
antly  extended hospital stay (9.98 days) which is similar to a
uropean study (1998)24 which reported 9.8 days.
In our study a single pre-operative dose of antimicrobial
herapy was  given before the operative procedure which
s  in accordance with the various standard guidelines and
revious  studies also showed that single dose prophylaxis is
ot associated with increased rate of SSI when compared to
ultiple  dose regimens.25 In our study mean duration of pre-
perative  intravenous therapy was  0.75 ± 0.45 days, followed
y  mean post-operative intravenous therapy for 3.33 ± 2.24
nd  post-op oral therapy for 4.58 ± 3.34 days. However timing
f  administration of ﬁrst dose of antimicrobial pre-operatively
as  in compliance with the CDC guidelines.5 Mean duration
f  post-operative antimicrobial use was  7.88 days which
s  longer than reported by previous study from India, i.e., 5
Table 4 – Appropriateness of surgical prophylaxis based on Kun
Appropriate
Category I Category II Subtotal 
2(0.91%) 103(46.81%) 105(47.72%
Inappropriat
Category III Category IV Category V 
108(49.09%) 0(0%) 7(3.19%) 
Fishers exact test, p = 0.0165, signiﬁcant.days16 which may  be due to differences in prevalent practices.
All  patients received antimicrobials, in both the pre-operative
and  post-operative period, and no antimicrobial was  given in
the intra-operative period. Most commonly used drug group
for  prophylaxis was third generation cephalosporins, followed
by  metronidazole, and penicillin group similar to an Indian
study.17 In our study none of the patients received cefazolin
as  recommended by various guidelines.5–8
For surgical prophylaxis it is important to select an antimi-
crobial  with narrowest antibacterial spectrum to reduce the
emergence  of resistance, secondly the antimicrobial antibi-
otic  must be active against the most likely contaminating
microorganisms for that type of surgery, the ﬁrst-generation
cephalosporins are excellent agents for skin and soft tissue
infections owing to Streptococcus pyogenes and methicillin-
susceptible S. aureus. Hence a single dose of cefazolin just
before  surgery is the preferred prophylaxis for procedures
in’s criteria11 and surgical site infection rate (n = 220).
 therapy
SSI positive SSI negative
) 4 101
e therapy
Subtotal SSI positive SSI negative
115(52.28%) 15 100
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Table 5 – Core indicators for surgical audit based on SIGN guidelines.6
(a)Process measures
1 Was prophylaxis given for an operation included in local guidelines? No local guideline available
2 If prophylaxis was given for an operation not included in local guidelines,
was a clinical justiﬁcation for prophylaxis recorded in the case notes?
Justiﬁcation was not recorded in the case note
3 Was the ﬁrst dosage of prophylaxis given within 30 min of the start of
surgery?
Yes
4 Were the choice, dosage and route of administration consistent with local
guidelines for that procedure?
Consistent without guideline
5 Was the prescription written in the “once-only” section of the drug
prescription chart?
Not applicable
6 Was the duration of prophylaxis greater then 24 h? Yes
(b)Outcome measures
1 Surgical site infection rate = number of SSIs occurring
postoperatively/total number of operative procedures
19/220  = 0.0864 (8.64%)
2 Rate of SSIs occurring postoperatively in patients who receive
inappropriate prophylaxis (as deﬁned in guideline) compared with rate of
this infection in patients who receive appropriate prophylaxis, expressed
as a ratio
13.04/3.8 = 3.43
3 Rate of Clostridium difﬁcile infections occurring postoperatively in patients
who receive inappropriate prophylaxis (as deﬁned in guideline) compared
ropria
No  culture recorded Clostridium difﬁcile
infectionwith rate of this infection in patients who receive app
prophylaxis, expressed as a ratio
in which skin ﬂora are the likely pathogens. For patients
undergoing clean operative procedure for herniorrhaphy, a
clean procedure a single dose of cefazolin 1 g preoperatively
and for appendectomy, a clean contaminated surgery single
preoperative intravenous dose of either cefotetan or cefoxitin
1  g is recommended.5–8 Therefore, it is recommended that
the  use of third generation cephalosporins such as ceftri-
axone  and cefotaxime be avoided in surgical prophylaxis as
it  may  be required later if patient develops serious sepsis
For  herniorrhaphy use of cefazolin is appropriate, while in
case  of appendectomy third generation cephalosporins have
been  used as substitute for cefotetan and cefoxitin in our
study  as in India cefazolin is available while cefotetan and
cefoxitin  are not marketed.26 However this is not justiﬁed, as
third  generation cephalosporins have to be spared for ther-
apeutic  purpose. Better option would be an alternative like
cefuroxime. Dirty and contaminated surgeries required broad
spectrum  antimicrobials coverage. Drugs like piperacillin,
tazobactum, linezolid were used mainly after diagnosis of SSI
for therapeutic purpose.
In  our study 52% patients received inappropriate chemo-
prophylaxis according to Kunin’s criteria.11 This ﬁnding is
in  accordance with earlier studies that showed 51.5%11 and
65.6%27 respectively. Most of the antimicrobials were  broad
spectrum, prescribed for longer duration which was  unwar-
ranted.  Inappropriate prophylaxis was  associated with higher
culture  positive (SSI positive) rates (13.04%) as compared to the
appropriate  prophylaxis (3.8%).
To our knowledge this study is ﬁrst of its kind in India.
Strength of this study was  the assessment of rationality
of  chemoprophylaxis based on Kunin’s criteria11 and SIGN
guideline6 as well as comparison of SSI rate in patients receiv-
ing  appropriate and inappropriate chemoprophylaxis. One of
the  limitations of our study is cross-sectional design of the
study.  Also there was  no patient follow up after discharge up
to  30 days which is required according to CDC deﬁnition of SSI
and  hence some cases of SSI after discharge from hospital mayte
be  missed. Patient post-discharge questionnaire was not used
and  further analysis based on quality of life could be done. Fur-
ther  studies with larger sample size can be planned including
additional cost borne by the patient because of inappropriate-
ness. In depth sub analysis into various types of surgeries and
various  drug regimens and infections can be done to select a
proper and rational regimen for an individual surgery using
other  guidelines. Kunin’s criteria11 is a preliminary evaluation
of  appropriateness, a further in-depth analysis of antimicro-
bial  prescription can be done according to the Modiﬁed Kunin’s
criteria,25 Giessen score,28 and by SWABs score.29 Evaluation
based on the combined scores from both the surgical wound
judgment  and prescription analysis can also be done.
Conclusion
Inappropriate chemoprophylaxis as evident in this study is
associated with higher SSI rate leading to prolongation of hos-
pital  stay and increased number of drugs usage. Adoption
of  international standard and formulation of locally feasible
guidelines can help overcome this situation. However this is
a single center study and results of this study may  not be
generalized.
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